SAGE
Geode Capital Management’s Sage Therapeutics SAGE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.4M | Buy |
1,356,577
+53,200
| +4% | +$485K | ﹤0.01% | 2222 |
|
|
2025
Q1 | $10.4M | Buy |
1,303,377
+46,474
| +4% | +$370K | ﹤0.01% | 2273 |
|
|
2024
Q4 | $6.83M | Buy |
1,256,903
+14,049
| +1% | +$76.3K | ﹤0.01% | 2582 |
|
|
2024
Q3 | $8.98M | Buy |
1,242,854
+3,757
| +0.3% | +$27.1K | ﹤0.01% | 2450 |
|
|
2024
Q2 | $13.5M | Buy |
1,239,097
+47,766
| +4% | +$519K | ﹤0.01% | 2147 |
|
|
2024
Q1 | $22.3M | Buy |
1,191,331
+24,074
| +2% | +$451K | ﹤0.01% | 1865 |
|
|
2023
Q4 | $25.3M | Buy |
1,167,257
+61,744
| +6% | +$1.34M | ﹤0.01% | 1774 |
|
|
2023
Q3 | $22.8M | Buy |
1,105,513
+37,968
| +4% | +$781K | ﹤0.01% | 1740 |
|
|
2023
Q2 | $50.2M | Buy |
1,067,545
+27,300
| +3% | +$1.28M | 0.01% | 1251 |
|
|
2023
Q1 | $43.6M | Buy |
1,040,245
+32,815
| +3% | +$1.38M | 0.01% | 1295 |
|
|
2022
Q4 | $38.4M | Buy |
1,007,430
+43,476
| +5% | +$1.66M | 0.01% | 1336 |
|
|
2022
Q3 | $37.7M | Buy |
963,954
+9,581
| +1% | +$375K | 0.01% | 1290 |
|
|
2022
Q2 | $30.8M | Buy |
954,373
+237,691
| +33% | +$7.68M | ﹤0.01% | 1458 |
|
|
2022
Q1 | $23.7M | Sell |
716,682
-191,547
| -21% | -$6.34M | ﹤0.01% | 1782 |
|
|
2021
Q4 | $38.6M | Buy |
908,229
+33,424
| +4% | +$1.42M | ﹤0.01% | 1494 |
|
|
2021
Q3 | $38.8M | Buy |
874,805
+101,121
| +13% | +$4.48M | 0.01% | 1484 |
|
|
2021
Q2 | $44M | Buy |
773,684
+116,220
| +18% | +$6.6M | 0.01% | 1416 |
|
|
2021
Q1 | $49.2M | Buy |
657,464
+19,377
| +3% | +$1.45M | 0.01% | 1245 |
|
|
2020
Q4 | $55.2M | Buy |
638,087
+36,687
| +6% | +$3.17M | 0.01% | 1032 |
|
|
2020
Q3 | $36.8M | Sell |
601,400
-19,000
| -3% | -$1.16M | 0.01% | 1093 |
|
|
2020
Q2 | $25.8M | Buy |
620,400
+25,158
| +4% | +$1.05M | 0.01% | 1310 |
|
|
2020
Q1 | $17.1M | Buy |
595,242
+23,685
| +4% | +$680K | ﹤0.01% | 1408 |
|
|
2019
Q4 | $41.3M | Buy |
571,557
+18,067
| +3% | +$1.3M | 0.01% | 1064 |
|
|
2019
Q3 | $77.6M | Buy |
553,490
+7,018
| +1% | +$985K | 0.02% | 673 |
|
|
2019
Q2 | $100M | Buy |
546,472
+21,686
| +4% | +$3.97M | 0.02% | 562 |
|
|
2019
Q1 | $83.5M | Buy |
524,786
+56,869
| +12% | +$9.04M | 0.02% | 606 |
|
|
2018
Q4 | $44.8M | Buy |
467,917
+32,033
| +7% | +$3.07M | 0.01% | 791 |
|
|
2018
Q3 | $61.6M | Buy |
435,884
+653
| +0.2% | +$92.2K | 0.02% | 708 |
|
|
2018
Q2 | $68.1M | Buy |
435,231
+7,357
| +2% | +$1.15M | 0.02% | 632 |
|
|
2018
Q1 | $68.9M | Buy |
427,874
+46,978
| +12% | +$7.57M | 0.02% | 609 |
|
|
2017
Q4 | $62.7M | Buy |
380,896
+72,790
| +24% | +$12M | 0.02% | 615 |
|
|
2017
Q3 | $19.2M | Buy |
308,106
+14,922
| +5% | +$930K | 0.01% | 1271 |
|
|
2017
Q2 | $23.3M | Buy |
293,184
+25,323
| +9% | +$2.02M | 0.01% | 1065 |
|
|
2017
Q1 | $19M | Buy |
267,861
+23,682
| +10% | +$1.68M | 0.01% | 1181 |
|
|
2016
Q4 | $12.5M | Buy |
244,179
+18,418
| +8% | +$940K | 0.01% | 1439 |
|
|
2016
Q3 | $10.4M | Buy |
225,761
+85,087
| +60% | +$3.92M | 0.01% | 1469 |
|
|
2016
Q2 | $4.24M | Buy |
140,674
+20,924
| +17% | +$630K | ﹤0.01% | 2022 |
|
|
2016
Q1 | $3.84K | Buy |
119,750
+39,100
| +48% | +$1.25K | ﹤0.01% | 2038 |
|
|
2015
Q4 | $4.7M | Buy |
80,650
+5,313
| +7% | +$310K | ﹤0.01% | 1915 |
|
|
2015
Q3 | $3.19M | Buy |
75,337
+2,445
| +3% | +$103K | ﹤0.01% | 2137 |
|
|
2015
Q2 | $5.32M | Buy |
72,892
+35,164
| +93% | +$2.57M | ﹤0.01% | 1845 |
|
|
2015
Q1 | $1.9M | Buy |
37,728
+2,942
| +8% | +$148K | ﹤0.01% | 2477 |
|
|
2014
Q4 | $1.27M | Buy |
34,786
+10,057
| +41% | +$368K | ﹤0.01% | 2694 |
|
|
2014
Q3 | $778K | Buy |
+24,729
| New | +$778K | ﹤0.01% | 2942 |
|